|
About the Nitrosamines in the News category
|
|
0
|
389
|
April 14, 2021
|
|
Pharmaceutical industry wants FDA to extend deadline for testing novel nitrosamines
|
|
5
|
1058
|
July 20, 2024
|
|
Novartis pauses some trials of cancer drug Kisqali to fix manufacturing
|
|
12
|
1243
|
April 16, 2024
|
|
Withdrawal of application for the marketing authorisation of Dabigatran etexilate
|
|
1
|
270
|
June 30, 2024
|
|
Cinacalcet Recall
|
|
1
|
283
|
June 13, 2024
|
|
Namibia Medicines Regulatory council (NMRC) has withdrawn all ranitidine products from the Namibian market
|
|
0
|
192
|
May 23, 2024
|
|
In light of recently evolving regulatory guidance on intake limits for nitrosamines in medications, enrollment of new patients in ribociclib early breast cancer (eBC) studies has been paused by Novartis in alignment with health authorities
|
|
0
|
226
|
May 21, 2024
|
|
Namibia Medicines Regulatory Council (NMRC) issues order for Withdrawal of all Ranitidine containing products from Namibian market due to NDMA impurities
|
|
0
|
244
|
May 20, 2024
|
|
Ranitidine back in the news!
|
|
3
|
330
|
May 19, 2024
|
|
Controversial but Public Report
|
|
4
|
631
|
April 6, 2024
|
|
Korean drug manufacturers are taking voluntary action by recalling or suspending the sales of tamsulosin, citing potential NDSRI impurity, N-Nitroso-tamsulosin concern
|
|
19
|
1048
|
April 18, 2024
|
|
Nitrosamine Impurity Test Market expected to grow exponentially by 2029
|
|
0
|
547
|
November 19, 2023
|
|
Nitrosamines in Bacon: a Case Study of Balancing Risks
|
|
1
|
261
|
March 20, 2024
|
|
NEWS! New USP Community on qNMR
|
|
0
|
322
|
March 1, 2024
|
|
Quality Officer Call for a New approach to Reduce Post Approval Complexity
|
|
0
|
276
|
February 28, 2024
|
|
๐ฐ Nitrosamine measures might disrupt anesthetic supply, Dr. Eric Tichy says
|
|
4
|
464
|
January 26, 2024
|
|
FDA leaders detail reorg plans Webinar
|
|
0
|
268
|
January 23, 2024
|
|
๐ช๐บ Ph. Eur. Commission adopts revised general monographs 2034 and 2619 after inclusion of new paragraph on control of N-nitrosamines
|
|
1
|
861
|
January 22, 2024
|
|
US FDA- Generic Drug Science and Research Priority Initiatives for Fiscal Year (FY) 2024
|
|
0
|
380
|
January 18, 2024
|
|
Reflective Beginnings: We have to be in the driver's seat
|
|
4
|
526
|
January 9, 2024
|
|
๐จโ๐ป Nitrosamines Trends in Google
|
|
0
|
416
|
January 8, 2024
|
|
๐ Happy Holiday and a Nitrosamines-free 2024!
|
|
8
|
769
|
January 7, 2024
|
|
ISP (Chile) announced the voluntary market withdrawal of Atomoxetine DP (40mg & 80mg) due presence of Nitroso-Atomoxetine
|
|
5
|
1309
|
December 14, 2023
|
|
4000 Members Milestone ๐
|
|
18
|
813
|
November 3, 2023
|
|
ๅ
ณไบ2023่ฏ็ฉๆ่ดจๆงๅถๅฝ้
ไบคๆตไผ็่ต่ฎฏ
|
|
1
|
437
|
September 29, 2023
|
|
Singapore: HSA issues retail-level recalls for batches of Apo-Amitriptyline and Apo-Acyclovir tablets due to nitrosamine impurity concerns
|
|
0
|
552
|
September 4, 2023
|
|
Apotex Inc. Canada is recalling one lot of APO-Amitriptyline due to presence of nitrosamine impurity, N-nitrosodimethylamine (NDMA) above the acceptable limit at the 48-month stability testing timepoint
|
|
15
|
1322
|
September 3, 2023
|
|
Fluoxetin Recall - Austria
|
|
6
|
746
|
July 28, 2023
|
|
European Pharmacopoeia Commission revises position on nitrosamine impurities
|
|
2
|
604
|
July 28, 2023
|
|
๐ง๐ท ANVISA (Brasil) denies registration
|
|
0
|
481
|
July 27, 2023
|